Spyre Therapeutics, Inc.SYRENASDAQ
LOADING
|||
Switch Symbol:
Operating Income Contraction
Trending higher, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-208.57M
↓ 140% below average
Average (9y)
$-86.95M
Historical baseline
Range
High:$-11.31M
Low:$-242.30M
CAGR
+38.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-208.57M | +13.9% |
| 2023 | $-242.30M | -185.8% |
| 2022 | $-84.78M | -29.1% |
| 2021 | $-65.65M | +19.4% |
| 2020 | $-81.48M | -1.4% |
| 2019 | $-80.33M | -76.7% |
| 2018 | $-45.46M | -64.3% |
| 2017 | $-27.68M | -26.3% |
| 2016 | $-21.91M | -93.6% |
| 2015 | $-11.31M | - |